可视电话面临新机遇
摘要
１ 国内外发展情况美国ＡＴ＆Ｔ公司于多年前推出了一种每秒可传送１０幅彩色图像的可视电话。该机曾进入我国展示和销售，价格达５０００余元。后来，ＡＴ＆Ｔ公司和日本夏普公司合作，开发出了传输速度更快的可视电话新机种。荷兰飞利浦公司推出的一种彩色可视电话，只...
出处
《电信快报》
2000年第2期42-42,共1页
Telecommunications Information
二级参考文献33
-
1Mond HG, Proclemer A. The 11 th world and implantablc World Society of survey of cardiac pacing calendar year 2009: a Arrhythmia' s project[J]. Pacing Clin Electro- physio1,2011,34 : 1013-1027.
-
2Yokoshiki H, Mitsuyama H, Watanabe M, et al. Anticoagulation management in the perioperative phase of implantable cardioverter defibrillator implantation[ J]. Circ J,2013,77 : 2003-2008.
-
3Ohlow MA, Laner B, Brunelli M, et al. Incidence and predictors of perieardial effusion after permanent heart rhythm device implan- tation: Prospective evaluation of 968 consecutive patients[ J ]. Circ J,2013,77 : 975-981.
-
4Ozcan KS, Osmonov D,Ylldmm E, et al. Hematoma complicating permanent pacemaker implantation: The role of periprocedural anti-platelet or anticoagulant therapy[ J]. ] Cardiol, 2013,62: 127-130.
-
5Douketis JD,Johnson JA,Turpie AG. Low-moleeular-weigbt hepa- tin as bridging anticoagulation during interruption of warfarin : as- sessment of a standardized periprocedural anticoagulation regimen [J]. Arch Intern Med,2004,164: 1319-1326.
-
6Wiegand UK, LeJeune D, Boguschewski F, et al. Pocket hemato- ma after pacemaker or implantable cardioverter defibrillator surger- y : influence of patient morbidity, operation strategy, and perioper- ative antiplatelet/antieoagulation therapy [ J ]. Chest, 2004,126 : 1177-1186.
-
7Aggarwal RK, Connelly DT, Ray SG,et al. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems[ J]. Br Heart J, 1995,73:571-575.
-
8Jamula E, Dotaketis JD, Sehulman S. Perioparative anticoagula- tion in patients having implantation of a cardiac pacemaker or de- fibrillator: a systematic review and practical management guide [ J ]. J Thmmb Hacmost,2008,6 : 1615-1621.
-
9Phibbs B, Marriott HI. Complications of permanent transvenous pacing[J]. N Engl J Med, 1985,312:1428-1432.
-
10Douketis JD, Berger PB, Dunn AS,et al. The perioperative man- agement of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edi- tion) [ J]. Chest,2008,133:299S-339S.
共引文献15
-
1陈磊.帧中继上的话音业务[J].电信快报,2000(2):22-24.
-
2杜举.对SSCOP重传机制的研究[J].电信快报,2000(2):32-35.
-
3安宁,曹瑞.起搏器围手术期不同抗凝方案安全性评价[J].西南国防医药,2017,27(8):802-805.
-
4丁鹏飞,李学文,薛宇龙,连俊.起搏器植入围术期抗栓药物应用与术后出血事件的观察[J].中华心律失常学杂志,2017,21(5):397-400. 被引量：5
-
5汪菁峰,汗祖热木·托合提,梁义秀,陈学颖,宿燕岗,葛均波.心血管植入型电子器械围术期不同抗栓策略的对比研究[J].中华心律失常学杂志,2019,23(4):341-347.
-
6承燕,张常莹,李宗斌,赵晓溪,王如兴.起搏器植入并发锁骨下挤压综合征15例的临床分析[J].中华心律失常学杂志,2019,23(6):535-539. 被引量：2
-
7徐晓华,张贤,沈燕萍,林颖.无导线起搏器植入患者的围术期护理[J].齐鲁护理杂志,2020,26(6):122-124. 被引量：8
-
8汤宝鹏,张澍,黄德嘉.无导线心脏起搏器,未来可期[J].中华心律失常学杂志,2021,25(1):5-9. 被引量：11
-
9闫丽荣,陈柯萍,戴研,孙奇,陈若菡,李玉秋,郭晓刚,张澍.无导线起搏器单中心临床应用的长期随访结果和3.0T磁共振成像的安全性研究[J].中华心律失常学杂志,2021,25(1):47-51. 被引量：6
-
10薄雅坤,周贤惠,芦颜美,汤宝鹏.无导线起搏临床应用进展[J].中华心律失常学杂志,2021,25(1):61-64. 被引量：4
